拜耳提出70亿美元新和解方案以了结农达诉讼

Core Viewpoint - Bayer is initiating a multi-billion dollar action to settle a long-standing legal issue regarding its flagship herbicide, Roundup, which has faced claims of causing cancer [1][3]. Group 1: Settlement Proposal - Bayer has proposed a settlement plan that allocates over $7 billion to pay compensation over the next 21 years [1][3]. - The settlement requires approval from a Missouri court, where many Roundup cases are pending [1][3]. Group 2: Legal Background - Since acquiring Monsanto for $63 billion in 2018, Bayer has been embroiled in lawsuits related to Roundup, the most widely used herbicide globally [1][3]. - Plaintiffs allege that glyphosate, the main ingredient in Roundup, is carcinogenic [1][3]. Group 3: Company Position - Bayer denies that its product causes cancer, citing that the U.S. Environmental Protection Agency and other regulatory bodies have deemed it safe for use [2][4]. - The company has already paid over $10 billion in Roundup settlement funds and resolved approximately 130,000 claims, with around 60,000 claims still pending [2][4]. - Bayer's CEO, Bill Anderson, stated that the current agreement addresses most eligible current and future cases, expressing a desire to control the litigation within the year [2][4].